Wegovy price at Maccabi

The price of Wegovy for weight loss in Israel ranges from 1,000 to 1,500 shekels per month, depending on the dosage and the pharmacy, and before insurance coverage. The Maccabi Health Services, like other health funds, offers partial or full subsidies in certain cases, mainly for patients who meet specific BMI criteria and comorbidities, such as type 2 diabetes or hypertension. It is important to note that Wegovy is not included in the full basket of medications for weight loss alone, but individual arrangements may be possible through supplementary insurance or health funds.

Obesity is a significant health challenge in Israel, with about 25% of the adult population suffering from obesity and an additional 40% being overweight. These figures highlight the growing need for effective and sustainable solutions, as the cost of treatment becomes a critical factor for many patients. The economic impact of obesity on the Israeli healthcare system is estimated to be in the billions of shekels per year, emphasizing the importance of access to treatments like Wegovy.

This guide will delve into the issue of Wegovy’s price in Israel, examine the possible insurance coverages through Maccabi Health Services and supplementary insurances, and present ways to cope with the cost. Additionally, we will review the mechanism of action of the drug, possible side effects, and therapeutic alternatives, in order to provide a comprehensive picture for patients considering this treatment.

The Science: How Wegovy Works for Weight Loss

Wegovy, whose active ingredient is Semaglutide, belongs to a class of drugs known as GLP-1 receptor agonists (Glucagon-like peptide-1 receptor agonists). GLP-1 is a natural hormone produced in the intestines in response to eating. Its main role is to regulate blood sugar levels by stimulating insulin secretion from the pancreas and reducing glucagon secretion (a hormone that raises blood sugar). Semaglutide mimics the action of natural GLP-1 but has a longer half-life, allowing for weekly administration.

In addition to its effect on blood sugar levels, Semaglutide significantly influences appetite and satiety regulation mechanisms. It acts on the hunger and satiety centers in the brain, particularly in the hypothalamus (the area of the brain responsible for appetite regulation), and reduces feelings of hunger. Additionally, it slows gastric emptying, leading to a prolonged feeling of fullness after meals and reducing overall food intake. The combination of appetite reduction and slowed gastric emptying contributes to a significant decrease in calorie consumption and, consequently, weight loss.

Understanding this unique mechanism of action is critical to understanding its cost. The high efficacy of Wegovy, demonstrated in clinical studies, makes it a sought-after treatment, but it also affects its pricing. The drug’s ability to influence multiple physiological mechanisms related to weight regulation—both in the digestive system and the brain—justifies the investment for many, even if it involves a significant out-of-pocket expense or requires effort to obtain insurance coverage.

Frequently Asked Questions About the Cost of Wigobi at Maccabi

Does Maccabi Health Fund Cover the Cost of Wigobi?

Maccabi Health Fund may partially or fully cover the cost of Wigobi in certain cases, but not generally for weight loss alone. Coverage depends on strict medical criteria, such as a particularly high BMI (usually over 35-40 with comorbidities) or in cases of type 2 diabetes. It is important to consult your family doctor or an endocrinologist at Maccabi to check eligibility and obtain prior approval.

What is the Expected Monthly Cost of Wigobi Without Insurance Coverage?

The monthly cost of Wigobi in Israel, without any insurance coverage, typically ranges from 1,000 to 1,500 shekels. This price may vary slightly between different pharmacies and depending on the required dosage. It is advisable to conduct a market survey among different pharmacies and even inquire about discount options for regular customers or loyalty programs.

Do Maccabi Supplementary Insurances (Maccabi Zahav/Maccabi Sheli) Offer Discounts?

Maccabi supplementary insurances, such as “Maccabi Zahav” and “Maccabi Sheli,” may offer reduced copayments or certain discounts on non-formulary medications, including Wigobi, subject to medical approval and meeting criteria. It is recommended to check the specific terms of your policy and contact the pharmacy department to understand the extent of possible coverage and the discount rate.

Are There Special Assistance Programs or Discounts for Diabetics?

Patients with type 2 diabetes who also suffer from obesity may qualify for broader coverage for Wigobi, as the medication is also used to treat diabetes (at lower doses, under the name Ozempic). In such cases, the treating physician can submit a special request to the health fund. Sometimes, drug manufacturers offer assistance programs or discount cards for patients who meet certain criteria; it is advisable to inquire about this.

What Are the Criteria for Approval of Wigobi Through Maccabi?

The criteria for obtaining approval for Wigobi through Maccabi generally include a high BMI (usually over 30 with comorbidities such as hypertension, dyslipidemia, or diabetes, or a BMI over 35 without comorbidities), proven unsuccessful attempts at lifestyle changes (diet and exercise), and a recommendation from a specialist physician (such as an endocrinologist or an internist).

In-Depth Guide to Success with the Cost of Wigobi at Maccabi

Step 1: Medical Evaluation and Prescription

The first step is to schedule an appointment with your family doctor or an endocrinologist at Maccabi Health Fund. The doctor will assess your health status, review your medical history, and determine if you meet the medical criteria for treatment with Wigobi. It is important to be honest about previous weight loss attempts and discuss your expectations from the treatment. Only a doctor can decide if Wigobi is suitable for you.

Step 2: Checking Eligibility for Insurance Coverage

After receiving the prescription, contact the clinic or the pharmacy department at Maccabi with the prescription and relevant medical documents. Request to check your eligibility for insurance coverage, either through the regular formulary (in exceptional cases) or through supplementary insurances (Maccabi Zahav/Sheli). You may be required to fill out specific forms or wait for approval from a medical committee.

Step 3: Comparing Prices Between Pharmacies

Even if you received partial coverage, there are still price differences between different pharmacies. Compare prices between Maccabi pharmacies, private pharmacies, and chain pharmacies. Often, you can find differences of tens or even hundreds of shekels. Do not hesitate to ask about special promotions or existing discount programs.

Step 4: Long-Term Budget Planning

Wigobi is a long-term treatment, so it is important to plan your expenses accordingly. Even if the monthly cost seems reasonable at first, it accumulates over time. Consider the total annual cost and ensure it fits your budget. In cases of financial difficulty, discuss with your doctor possible alternatives or additional ways to receive financial assistance.

Comparison Between Alternatives for Wegovy Price in Maccabi

When considering options for pharmacological treatment of obesity, cost is a decisive factor for many patients, especially in the context of insurance coverage through Maccabi health fund. The table above presents a comparison between Wegovy and similar medications from the same family (GLP-1 agonists) marketed in Israel, focusing on the estimated monthly cost and insurance coverage.

Wegovy and Ozempic contain the same active ingredient, Semaglutide, but Ozempic is primarily approved for the treatment of type 2 diabetes and has lower dosages, which is reflected in a lower price and broader coverage in the drug basket for diabetes patients. In contrast, Wegovy is specifically approved for weight loss at higher dosages, making it more effective for this purpose, but also more expensive and with more limited insurance coverage.

Saxenda, which contains Liraglutide, is another alternative approved for weight loss but requires a daily injection, which may be a disadvantage for some patients. Rybelsus is Semaglutide in tablet form, making it easier to take, but it is also currently approved mainly for diabetes and is not intended for weight loss only. The choice between medications depends on many factors, including efficacy, ease of use, side effect profile, and of course, cost and available insurance coverage.

General Clinical Facts – Wegovy Price in Maccabi

Clinical Background: Many patients suffering from significant overweight or obesity, often with comorbidities such as type 2 diabetes and hypertension, find it difficult to lose weight through diet alone. In these cases, medications like Wegovy, specifically intended for weight loss at higher dosages than equivalent diabetes treatments (like Ozempic), may be recommended by doctors.

Coverage and Treatment Aspects: Medication coverage for Wegovy, especially when the primary indication is weight loss and not just diabetes, may require a high out-of-pocket expense from health funds. Often, a bureaucratic process of submitting a special request through a specialist doctor (such as an endocrinologist) is required, and assistance in reducing costs may often be available through supplementary insurance (like “Maccabi Sheli”). Clinically, patients using Wegovy report significant weight loss, which can reach 15% or more of body weight within a few months, leading to significant improvements in metabolic parameters such as blood sugar and blood pressure levels.

These clinical data illustrate how Wegovy can assist patients dealing with obesity and related comorbidities, while addressing the challenges related to Wegovy’s price and its coverage in health funds in Israel, such as Maccabi.

Safety Profile: Managing Concerns Related to the Cost of Wegovy at Maccabi

The cost of Wegovy, especially in the absence of full insurance coverage, highlights the importance of prudent and safe use of the medication. Patients paying out of pocket should ensure they are receiving the best value for their health. Therefore, understanding the safety profile and managing side effects is critical, as is purchasing the medication only from authorized sources to prevent counterfeits or unsafe products.

Common Side Effects and Coping Strategies:

1. Nausea: The most common side effect. Start with a low dose and gradually increase (titration), eat small and frequent meals, and avoid fatty foods.
2. Vomiting: Similar to nausea, usually subsides with adaptation. In severe cases, consult a doctor.
3. Diarrhea/Constipation: Maintain adequate hydration. For diarrhea: temporarily avoid high-fiber foods. For constipation: increase fiber and fluid intake.
4. Abdominal Pain: Usually mild and transient. In case of severe or persistent pain, consult a doctor.
5. Heartburn/Reflux: Avoid lying down immediately after meals, reduce acidic foods.
6. Fatigue: Common during the adjustment phase. It is important to ensure adequate sleep.
7. Headaches: Can be treated with over-the-counter pain relievers. In severe cases, consult a doctor.
8. Dizziness: Usually mild. In case of severe dizziness, sit or lie down.

Special Populations and Relevant Considerations for Cost:

Diabetic Patients: Wegovy can lower blood sugar levels, so diabetic patients on other medications (such as insulin or sulfonylureas) should closely monitor their blood sugar levels to prevent hypoglycemia (sharp drop in blood sugar). In these cases, insurance coverage through the basket for Ozempic may be advantageous, which can serve as a cheaper alternative if the primary goal is blood sugar control with secondary weight loss.

History of Pancreatitis: Patients with a history of pancreatitis should exercise caution when using Wegovy. In case of severe abdominal pain radiating to the back, discontinue treatment and consult a doctor immediately. The cost of treatment in such a situation may be high, so prevention is important.

Pregnancy and Breastfeeding: Wegovy is not recommended for pregnant or breastfeeding women. Treatment should be discontinued at least two months before planning a pregnancy. Contraception during treatment is critical.

Kidney Issues: Dose adjustment is necessary for patients with severe kidney failure. Consult a doctor before starting treatment.

Myths vs. Reality About the Cost of Wegovy at Maccabi

Myth: Maccabi always covers Wegovy if I have obesity.

Reality: This is a common myth. Maccabi does not automatically cover Wegovy for everyone suffering from obesity. Coverage depends on strict medical criteria, such as very high BMI combined with comorbidities (such as diabetes, hypertension), and even then, it is often partial coverage through supplemental insurance rather than the regular health basket. Approval from a specialist doctor and prior authorization from the fund is required.

Myth: Wegovy is an expensive magic solution that eliminates the need for lifestyle changes.

Reality: While Wegovy is very effective, it is not a “magic solution.” Clinical studies have shown its highest effectiveness when combined with a comprehensive lifestyle change program, including a balanced diet and regular physical activity. The medication helps reduce appetite and increase feelings of fullness, but dietary choices and physical activity are still in the hands of the patient. Its high cost necessitates a serious investment in changing habits to maximize results.

Myth: There is no difference between Wegovy and Ozempic, and Ozempic is cheaper and therefore better.

Reality: Although both medications contain the same active ingredient (semaglutide), they are approved for different uses and in different dosages. Ozempic is approved for the treatment of type 2 diabetes, while Wegovy is specifically approved for the treatment of obesity at higher doses. While Ozempic is indeed cheaper and sometimes covered in the basket for diabetic patients, it is not intended solely for obesity treatment. Using lower doses of Ozempic for weight loss may be less effective and is considered “off-label” use (outside the approved indication).

Wegovy in Israel: A Perspective on the Price of Wegovy at Maccabi

The launch of Wegovy in Israel has created great anticipation among those suffering from obesity, but the issue of price and insurance coverage through health funds, particularly Maccabi, remains complex. As of now, Wegovy is not included in the health services basket as a standard treatment for weight loss alone. This means that most patients will be required to bear the full or partial cost of the medication.

Maccabi Health Services, like other health funds, offers partial coverage for Wegovy under supplementary insurance plans (“Maccabi Zahav”, “Maccabi Sheli”) but only after prior approval from a medical committee and meeting strict criteria. These criteria typically include a particularly high Body Mass Index (BMI) (for example, over 35 with comorbidities such as diabetes, hypertension, or dyslipidemia), as well as documentation of previous unsuccessful weight loss attempts. In cases of type 2 diabetes, the doctor may recommend Ozempic (the same active ingredient at a different dosage), which is covered in the drug basket, as a more effective and cost-efficient alternative.

The monthly cost of Wegovy, ranging from 1,000 to 1,500 shekels, represents a significant financial burden for many patients. This burden necessitates careful budget planning and a deep understanding of coverage options. It is important to remember that even if partial coverage is approved, there will still be a significant out-of-pocket expense. Therefore, it is advisable to consult with a family doctor or an endocrinologist at Maccabi, check eligibility, and obtain all relevant information before starting treatment to ensure that the treatment is financially sustainable.

Price of Wegovy at Maccabi – Summary

The price of Wegovy in Israel, particularly the coverage through Maccabi Health Services, is a complex and significant issue for many patients. Wegovy, as an effective treatment for weight loss, offers hope to individuals suffering from obesity, but its high cost and limited insurance coverage require careful understanding and planning. As of now, there is no blanket coverage in the health basket for Wegovy for weight loss purposes alone, but there are options for partial coverage through Maccabi’s supplementary insurance, subject to strict medical criteria and committee approval.

In summary, the following steps are recommended for patients considering treatment with Wegovy through Maccabi:

1. Medical Consultation: Consult with your family doctor or an endocrinologist at Maccabi to assess your suitability for treatment and obtain a prescription.
2. Check Eligibility for Coverage: Inquire with Maccabi about the coverage conditions under supplementary insurance (“Maccabi Zahav”, “Maccabi Sheli”) and submit a request for prior approval.
3. Price Comparison: Even with partial coverage, it is advisable to compare prices between different pharmacies to find the most cost-effective option.
4. Long-term Planning: Consider the monthly and annual cost of treatment and ensure it fits your budget.
5. Integration with a Healthy Lifestyle: Remember that the effectiveness of Wegovy is maximized when combined with proper nutrition and physical activity.

A comprehensive understanding of the economic and medical aspects will help you make an informed decision and maximize the chances of success in treatment.

Important Medical Disclaimer: The information in this article is for informational purposes only and does not constitute a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified physician or healthcare professional before taking any medication, changing dosages, or making any health-related decisions. Do not disregard medical advice or delay seeking medical attention because of something you read on this site.